Wavealert user story: The short hype about vaccines from Valneva

Hero Image

Realize profits with industry expertise & alarm function

The doctor Michael K. was a volunteer vaccinator during the coronavirus pandemic. In his private life, he is interested in shares and opened an account with WAVEALERT on the basis of a personal recommendation. This turned out to be helpful for the following investment strategy:

Due to his work as a vaccination worker, Michael knew that the vaccine manufacturer Valneva was in the approval process for an pot vaccine against Covid-19. Michael speculated that the successful approval should boost the pharmaceutical company's share price in the current coronavirus hysteria. Large parts of the capital market were understandably focused on the pharmaceutical sector at the time. Since the Valneva product, unlike other manufacturers such as Biontech, was already producing mRNA vaccines in large quantities, he estimated that the positive effect would only last for a short time, as the product appeared on the market too late.

What he needed was an alarm that could detect and report a positive, violent short burst (pump). Therefore, he created a delta alert with 15 percent increase within one day. After the approval was announced in April 2022, the share price actually jumped the following week and Michael sold his shares after the alert reported the increase. This was a good strategy: a few days later, the share price went down again, as expected.

Michael benefited on the one hand from the alarm function and on the other from his knowledge of the situation in the pharmaceutical industry. If you want to know more about such investment strategies, read our article "8 tips to strengthen your portfolio".

Don't miss a wave: Whether it's a sharp rise or a massive slump. Decide for yourself which developments you want to be notified about with the help of clever alert features. Choose whether you are interested in an absolute value or a specific change over a defined period of time.